Detailed information for compound 375282

Basic information

Technical information
  • TDR Targets ID: 375282
  • Name: 5-(4-dimethylaminophenyl)-6-[2-(6-morpholin-4 -ylpyridin-3-yl)ethynyl]pyrimidin-4-amine
  • MW: 400.476 | Formula: C23H24N6O
  • H donors: 1 H acceptors: 3 LogP: 2.67 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(c1ccc(cc1)c1c(N)ncnc1C#Cc1ccc(nc1)N1CCOCC1)C
  • InChi: 1S/C23H24N6O/c1-28(2)19-7-5-18(6-8-19)22-20(26-16-27-23(22)24)9-3-17-4-10-21(25-15-17)29-11-13-30-14-12-29/h4-8,10,15-16H,11-14H2,1-2H3,(H2,24,26,27)
  • InChiKey: AINVOEOJEKKMKB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-(4-dimethylaminophenyl)-6-[2-(6-morpholino-3-pyridyl)ethynyl]pyrimidin-4-amine
  • 5-(4-dimethylaminophenyl)-6-[2-(6-morpholino-3-pyridyl)ethynyl]-4-pyrimidinamine
  • [4-[4-amino-6-[2-(6-morpholino-3-pyridyl)ethynyl]pyrimidin-5-yl]phenyl]-dimethyl-amine
  • 89I

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adenosine kinase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Candida albicans adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus granulosus adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania braziliensis adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Brugia malayi Adenosine kinase-like Get druggable targets OG5_128398 All targets in OG5_128398
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania infantum adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania donovani adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Onchocerca volvulus Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma japonicum ko:K00856 adenosine kinase [EC2.7.1.20], putative Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus multilocularis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Cryptosporidium parvum adenosine kinase like ribokinase Get druggable targets OG5_128398 All targets in OG5_128398
Toxoplasma gondii kinase, pfkB family protein Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Neospora caninum GG10762, related Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania major adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Babesia bovis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania mexicana adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Candida albicans putative adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma congolense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma cruzi adenosine kinase, putative adenosine kinase 345 aa 337 aa 35.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Trypanosoma cruzi adenosine kinase, putative 0.0105 0.2877 0.5
Schistosoma mansoni peroxidasin 0.0255 0.9045 1
Onchocerca volvulus Peroxidase homolog 0.0255 0.9045 0.9045
Leishmania major adenosine kinase, putative 0.0105 0.2877 0.5
Brugia malayi Peroxidasin 0.0255 0.9045 1
Trypanosoma brucei adenosine kinase, putative 0.0105 0.2877 0.5
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Echinococcus multilocularis adenosine kinase 0.0105 0.2877 0.318
Brugia malayi hypothetical protein 0.0255 0.9045 1
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Echinococcus granulosus peroxidasin 0.0255 0.9045 1
Schistosoma mansoni adenosine kinase 0.0105 0.2877 0.318
Loa Loa (eye worm) animal heme peroxidase 0.0255 0.9045 1
Brugia malayi Pre-SET motif family protein 0.0245 0.8611 0.952
Echinococcus multilocularis peroxidasin 0.0255 0.9045 1
Onchocerca volvulus Dual oxidase homolog 0.0255 0.9045 0.9045
Trichomonas vaginalis set domain proteins, putative 0.0278 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Brugia malayi Animal haem peroxidase family protein 0.0255 0.9045 1
Onchocerca volvulus Peroxidasin homolog 0.0255 0.9045 0.9045
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Toxoplasma gondii kinase, pfkB family protein 0.0105 0.2877 1
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Loa Loa (eye worm) animal heme peroxidase 0.0255 0.9045 1
Onchocerca volvulus 0.0255 0.9045 0.9045
Schistosoma mansoni peroxidasin 0.0255 0.9045 1
Brugia malayi Animal haem peroxidase family protein 0.0255 0.9045 1
Plasmodium vivax SET domain protein, putative 0.0035 0 0.5
Onchocerca volvulus Peroxidase homolog 0.0255 0.9045 0.9045
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Trypanosoma brucei adenosine kinase, putative 0.0105 0.2877 0.5
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Loa Loa (eye worm) animal heme peroxidase 0.0255 0.9045 1
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Loa Loa (eye worm) hypothetical protein 0.0105 0.2877 0.318
Brugia malayi Blistered cuticle protein 3 0.0255 0.9045 1
Onchocerca volvulus 0.0255 0.9045 0.9045
Echinococcus granulosus adenosine kinase 0.0105 0.2877 0.318
Loa Loa (eye worm) blistered cuticle protein 3 0.0255 0.9045 1
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Trypanosoma cruzi adenosine kinase, putative 0.0105 0.2877 0.5
Brugia malayi Animal haem peroxidase family protein 0.0255 0.9045 1
Schistosoma mansoni adenosine kinase 0.0105 0.2877 0.318
Onchocerca volvulus Chorion peroxidase homolog 0.0255 0.9045 0.9045
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1
Brugia malayi Animal haem peroxidase family protein 0.0255 0.9045 1
Brugia malayi Adenosine kinase-like 0.0105 0.2877 0.318
Onchocerca volvulus 0.0255 0.9045 0.9045
Loa Loa (eye worm) animal heme peroxidase 0.0255 0.9045 1
Onchocerca volvulus Peroxidasin homolog 0.0255 0.9045 0.9045
Onchocerca volvulus 0.0093 0.2385 0.2385
Loa Loa (eye worm) pre-SET domain-containing protein family protein 0.0245 0.8611 0.952
Brugia malayi Animal haem peroxidase family protein 0.0255 0.9045 1
Loa Loa (eye worm) hypothetical protein 0.0255 0.9045 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 44 % Reduction of formalin-induced nociception in rat at 10 umol/kg, ip by paw flinching test ChEMBL. 17197188
Activity (functional) = 100 % Analgesic activity in mouse assessed as maximal protective effect at 30 umol/kg, ip by hot plate test ChEMBL. 17197188
Activity (functional) = 100 % Analgesic activity in mouse assessed as maximal protective effect at 30 umol/kg, ip by hot plate test ChEMBL. 17197188
CL (ADMET) = 1 L/hr.Kg Plasma clearance in rat at 5 umol/kg, iv ChEMBL. 17197188
Cmax (ADMET) = 0.08 ug ml-1 Cmax in rat at 5 umol/kg, po ChEMBL. 17197188
F (ADMET) = 9 % Bioavailability in rat at 5 umol/kg, po ChEMBL. 17197188
IC50 (binding) = 2 nM Inhibition of cytosolic adenosine kinase ChEMBL. 17197188
IC50 (binding) = 2 nM Inhibition of cytosolic adenosine kinase ChEMBL. 17197188
IC50 (binding) = 68 nM Inhibition of human cytosolic AK ChEMBL. 17154503
IC50 (functional) = 68 nM Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation ChEMBL. 17197188
IC50 (binding) = 68 nM Inhibition of human cytosolic AK ChEMBL. 17154503
IC50 (functional) = 68 nM Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation ChEMBL. 17197188
Stabilty (ADMET) = 21 % Metabolic stability in rat hepatocyte after 24 hrs ChEMBL. 17197188
Stabilty (ADMET) = 74 % Metabolic stability in human liver microsomes after 1 hr ChEMBL. 17197188
t1/2 (ADMET) = 0.5 hr Half life in rat at 5 umol/kg, iv ChEMBL. 17197188
Vbeta (ADMET) = 0.7 L/Kg Volume of distribution in rat at 5 umol/kg, iv ChEMBL. 17197188

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.